Kristian M Hargadon

10PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyCancer geneticsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 26, 2025
A Highly Sensitive Tissue-specific qRT-PCR-based Assay for Detection of Melanoma Cells in Tumor-Draining Lymph Nodes.

Kristian M Hargadon, Travis B Goodloe

|Feb 11, 2025
Lymph Node Invasion by Melanoma Cells Is Not Required for the Induction of Incomplete Differentiation by Tumor-Specific CD8+ T Cells.

Kristian M Hargadon, Travis B Goodloe, Stephen L Woodall

|Feb 06, 2023
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer.

Kristian M Hargadon, Elijah W Strong

|Jan 11, 2023
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer.

Kristian M Hargadon

|Sep 12, 2022
A Bioinformatic Approach to Enhance Undergraduate Student Understanding of the Cancer-Immunity Cycle.

Kristian M Hargadon

|Jun 14, 2022
Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective.

Kristian M Hargadon, Travis B Goodloe, Nathaniel D Lloyd

Pageof 2

Frequent Collaborators